The influence of bariatric surgery on serum levels of irisin and nesfatin-1

References

• Kelly T, Yang W, Chen C-S, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32:1431–1437.
   PubMed Web of Science ®Google Scholar
• van den Oever R, Volckaert C. Bariatric surgery trends in Belgium. The health insurer's view. Acta Chir Belg. 2006;106:641–646.
   PubMed Web of Science ®Google Scholar
• Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367–377.
   PubMed Web of Science ®Google Scholar
• Mariscalco G, Wozniak MJ, Dawson AG, et al. Body mass index and mortality among adults undergoing cardiac surgery: a nationwide study with a systematic review and meta-analysis. Circulation. 2017;135:850–863.
   PubMed Web of Science ®Google Scholar
• Jerant A, Franks P. Body mass index, diabetes, hypertension, and short-term mortality: a population-based observational study, 2000-2006. J Am Board Fam Med. 2012;25:422–431.
   PubMed Web of Science ®Google Scholar
• Panteliou E, Miras AD. What is the role of bariatric surgery in the management of obesity? Climacteric. 2017;20:97–102.
   PubMed Web of Science ®Google Scholar
• Silecchia G, Casella G, Rizzello M. Surgical treatment of type 2 diabetes. Acta Chir Belg. 2009;109:292–299.
   PubMed Web of Science ®Google Scholar
• Dumon K, Savulionyte G. Bariatric surgery produces greater weight loss and improvements in medical conditions than non-surgical treatment of obesity. Evid Based Med. 2014;19:2401.
   Google Scholar
• Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–1832.
   PubMed Web of Science ®Google Scholar
• Janik MR, Stanowski E, Paśnik K. Present status of bariatric surgery in Poland. WIITM. 2016;1:22–25.
   Web of Science ®Google Scholar
• Gale SM, Castracane VD, Mantzoros CS. Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr. 2004;134:295–298.
   PubMed Web of Science ®Google Scholar
• Staiger H, Bohm A, Scheler M, et al. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived “browning” factor irisin, determines insulin sensitivity. PLoS One. 2013;8:e61903.
   PubMed Web of Science ®Google Scholar
• Algul S, Ozkan Y, Ozcelik O. Serum nesfatin-1 levels in patients with different glucose tolerance levels. Physiol Res. 2016;65:979–985.
   PubMed Web of Science ®Google Scholar
• Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/Irisin is not only a myokine but also an adipokine. PLoS One. 2013;8:1–10.
   Web of Science ®Google Scholar
• de Macêdo SM, de Farias Lelis D, Mendes KL, et al. Effects of dietary macronutrient composition on FNDC5 and irisin in mice skeletal muscle. Metab Syndr Relat Disord [Internet]. 2017;15:161–169. Available from: http://online.liebertpub.com/doi/10.1089/met.2016.0109.
   PubMed Web of Science ®Google Scholar
• Oh-I S, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443:709–712.
   PubMed Web of Science ®Google Scholar
• Foo KS, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience. 2008;156:563–579.
   PubMed Web of Science ®Google Scholar
• Pukajło K, Kolackov K, Łaczmański Ł, et al. Irisin – a new mediator of energy homeostasis. Postepy Hig Med Dosw (Online). 2015;69:233–242.
   PubMedGoogle Scholar
• Harvey EJ, Arroyo K, Korner J, et al. Hormone changes affecting energy homeostasis after metabolic surgery. Mt Sinai J Med. 2010;77:446–465.
   PubMedGoogle Scholar
• Major P, Matłok M, Pędziwiatr M, et al. Changes in levels of selected incretins and appetite-controlling hormones following surgical treatment for morbid obesity. WIITM. 2015;3:458–465.
   Web of Science ®Google Scholar
• Benaiges D, Flores Le-Roux JA, Pedro-Botet J, et al. Sleeve gastrectomy and Roux-en-Y gastric bypass are equally effective in correcting insulin resistance. Int J Surg. 2013;11:309–313.
   PubMed Web of Science ®Google Scholar
• Budzyński A, Major P, Głuszek S, et al. Polskie rekomendacje w zakresie chirurgii bariatrycznej i metabolicznej [Polish recommendations for bariatric and metabolic surgery]. Med Prakt – Chir. 2016;6:13–25.
   Google Scholar
• Wyleżoł M, Paśnik K, Dąbrowiecki S, et al. Polish recommendations for bariatric surgery. Videosurgery Other Miniinvasive Tech. 2009;4(Suppl 1):S5–S8.
   Google Scholar
• Małczak P, Pisarska M, Piotr M, et al. Enhanced recovery after bariatric surgery: systematic review and meta-analysis. Obes Surg. 2017;27:226–235.
   PubMed Web of Science ®Google Scholar
• Matłok M, Pędziwiatr M, Major P, et al. One hundred seventy-nine consecutive bariatric operations after introduction of protocol inspired by the principles of enhanced recovery after surgery (ERAS®) in bariatric surgery. Med Sci Monit. 2015;21:791–797.
   PubMed Web of Science ®Google Scholar
• Proczko M, Kaska L, Twardowski P, et al. Implementing enhanced recovery after bariatric surgery protocol: a retrospective study. J Anesth. 2016;30:170–173.
   PubMed Web of Science ®Google Scholar
• Major P, Wysocki M, Pędziwiatr M, et al. Risk factors for complications of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass. Int J Surg. 2017;37:71–78.
   PubMed Web of Science ®Google Scholar
• Quercia I, Dutia R, Kotler DP, et al. Gastrointestinal changes after bariatric surgery. Diabetes Metab. 2014;40:87–94.
   PubMed Web of Science ®Google Scholar
• Major P, Wysocki M, Janik M, et al. Impact of age on postoperative outcomes in bariatric surgery. Acta Chir Belg 2018;118:307–314.
   Web of Science ®Google Scholar
• Ruiz-Tovar J, Alsina ME, Alpera MR. Improvement of nonalcoholic fatty liver disease in morbidly obese patients after sleeve gastrectomy: association of ultrasonographic findings with lipid profile and liver enzymes. Acta Chir Belg. 2017;117:363–369.
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463–468.
   PubMed Web of Science ®Google Scholar
• Elsen M, Raschke S, Eckel J. Browning of white fat: Does irisin play a role in humans? J Endocrinol. 2014;222:R25–38.
   PubMed Web of Science ®Google Scholar
• Novelle MG, Contreras C, Romero-Picó A, et al. Irisin, two years later. Int J Endocrinol. 2013;2013:746281.
   PubMed Web of Science ®Google Scholar
• Crujeiras AB, Zulet MA, Lopez-Legarrea P, et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism. 2014;63:520–531.
   PubMed Web of Science ®Google Scholar
• Elbelt U, Hofmann T, Stengel A. Irisin: what promise does it hold?. Curr Opin Clin Nutr Metab Care. 2013;16:541–547.
   PubMed Web of Science ®Google Scholar
• Fukushima Y, Kurose S, Shinno H, et al. Effects of body weight reduction on serum irisin and metabolic parameters in obese subjects. Diabetes Metab J. 2016;40:386–395.
   PubMed Web of Science ®Google Scholar
• Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61:1725–1738.
   PubMed Web of Science ®Google Scholar
• Demirpence M, Yilmaz H, Colak A, et al. The effect of sleeve gastrectomy on serum irisin levels in patients with morbid obesity. Endokrynol Pol. 2016;67:481–486.
   PubMed Web of Science ®Google Scholar
• Goebel-Stengel M, Wang L. Central and peripheral expression and distribution of NUCB2/nesfatin-1. Curr Pharm Des. 2013;19:6935–6940.
   PubMed Web of Science ®Google Scholar
• Elmquist JK, Coppari R, Balthasar N, et al. Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J Comp Neurol. 2005;493:63–71.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ma X, Wang Q, et al. Nesfatin-1 correlates with hypertension in overweight or obese Han Chinese population. Clin Exp Hypertens. 2014;1963:1–6.
   Google Scholar
• Xia Z, Wang G, Li H, et al. Influence of bariatric surgery on the expression of nesfatin-1 in rats with type 2 diabetes mellitus. Curr Pharm Des. 2015;21:1464–1471.
   PubMed Web of Science ®Google Scholar
• Lee W-J, Chen C-Y, Ser K-H, et al. Differential influences of gastric bypass and sleeve gastrectomy on plasma nesfatin-1 and obestatin levels in patients with type 2 diabetes mellitus. Curr Pharm Des. 2013;19:5830–5835.
   PubMed Web of Science ®Google Scholar